Research Programme: Tellurium based compounds - Qrons
Alternative Names: Tellurium based compounds - QronsLatest Information Update: 22 Sep 2023
Price :
$50 *
At a glance
- Originator Qrons
- Class Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Traumatic brain injuries
Most Recent Events
- 09 Aug 2023 Qrons files a provisional patent application with USPTO for tellurium based compounds in USA
- 17 Jul 2023 Bar Ilan University and Qrons enter into an licensing agreement for an the university's IP in Tellurium based compounds .
- 14 Dec 2022 Preclinical trials in Traumatic brain injuries in USA (Parenteral)